Three year continuous abstinence in a smoking cessation study using the nicotine transdermal patch

A total of 305 subjects from Sydney were randomly allocated to receive either an active (24 hour transdermal nicotine patch over a 10 week course) or placebo nicotine patch. All subjects participated in a multicomponent cognitive–behavioural smoking cessation programme over five weeks in two-hour gr...

Full description

Saved in:
Bibliographic Details
Published in:Heart (British Cardiac Society) 1997-12, Vol.78 (6), p.617-618
Main Authors: Richmond, Robyn L, Kehoe, Linda, Neto, Abilio Cesar de Almeida
Format: Article
Language:English
Subjects:
Administration, Cutaneous
Behavior Therapy
Biological and medical sciences
Combined Modality Therapy
Confidence intervals
Drug Administration Schedule
Ganglionic Stimulants - administration & dosage
Humans
Medical sciences
Nicotine
Nicotine - administration & dosage
nicotine patches
Short Report
Smoking Cessation
Time Factors
Tobacco, tobacco smoking
Toxicology
Transdermal medication
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b572t-132699ef78065dd2c2332451584221b220a6581c698451ee2d407d696629a0f03
cites
container_end_page 618
container_issue 6
container_start_page 617
container_title Heart (British Cardiac Society)
container_volume 78
creator Richmond, Robyn L
Kehoe, Linda
Neto, Abilio Cesar de Almeida
description A total of 305 subjects from Sydney were randomly allocated to receive either an active (24 hour transdermal nicotine patch over a 10 week course) or placebo nicotine patch. All subjects participated in a multicomponent cognitive–behavioural smoking cessation programme over five weeks in two-hour group sessions. The continuous abstinence rates at three years (validated by expired carbon monoxide) were 13.8% for the active group and 5.2% for placebo group (p = 0.011). The active nicotine patch with behavioural therapy achieved more than double the abstinence rates early in treatment compared with placebo and this difference was maintained throughout the three year follow up.
doi_str_mv 10.1136/hrt.78.6.617
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1892325</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79553063</sourcerecordid><originalsourceid>FETCH-LOGICAL-b572t-132699ef78065dd2c2332451584221b220a6581c698451ee2d407d696629a0f03</originalsourceid><addsrcrecordid>eNp9kUuLFDEUhQtRxnF051YIKOPGavOovDaC0_jCQUHGB25CKpWaSk9V0iYpsf-9Kbpp1IWrXHK-HE7uqaqHCK4QIuz5EPOKixVbMcRvVaeoYaLGEH27XWZCac0g4XereyltIISNFOykOpENh0I0p1V7NURrwc7qCEzw2fk5zAnoNpXRemOB80CDNIUb56-BsSnp7IIHKc_dDsxpuc2DBd6ZsDwBOWqfOhsnPYKtzma4X93p9Zjsg8N5Vn1-_epq_ba-_Pjm3frlZd1SjnONCGZS2p4LyGjXYYMJwQ1FVDQYoxZjqBkVyDApyq21uGsg75hkDEsNe0jOqhd73-3cTrYz1pcoo9pGN-m4U0E79bfi3aCuw0-FhMQE02JwfjCI4cdsU1aTS8aOo_a2LEVxSSmBjBTw8T_gJszRl88pVOJzgXGDC_VsT5kYUoq2P0ZBUC3NqdKc4kIxVZor-KM_4x_hQ1VFf3LQdTJ67MuajUtHDENBMF5s6j3mUra_jrKON4pxwqn68GWt3n9l3yW9-KQW26d7vp02_w_4GxdrvUM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1780782242</pqid></control><display><type>article</type><title>Three year continuous abstinence in a smoking cessation study using the nicotine transdermal patch</title><source>Open Access: PubMed Central</source><creator>Richmond, Robyn L ; Kehoe, Linda ; Neto, Abilio Cesar de Almeida</creator><creatorcontrib>Richmond, Robyn L ; Kehoe, Linda ; Neto, Abilio Cesar de Almeida</creatorcontrib><description>A total of 305 subjects from Sydney were randomly allocated to receive either an active (24 hour transdermal nicotine patch over a 10 week course) or placebo nicotine patch. All subjects participated in a multicomponent cognitive–behavioural smoking cessation programme over five weeks in two-hour group sessions. The continuous abstinence rates at three years (validated by expired carbon monoxide) were 13.8% for the active group and 5.2% for placebo group (p = 0.011). The active nicotine patch with behavioural therapy achieved more than double the abstinence rates early in treatment compared with placebo and this difference was maintained throughout the three year follow up.</description><identifier>ISSN: 1355-6037</identifier><identifier>EISSN: 1468-201X</identifier><identifier>DOI: 10.1136/hrt.78.6.617</identifier><identifier>PMID: 9470884</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and British Cardiovascular Society</publisher><subject>Administration, Cutaneous ; Behavior Therapy ; Biological and medical sciences ; Combined Modality Therapy ; Confidence intervals ; Drug Administration Schedule ; Ganglionic Stimulants - administration &amp; dosage ; Humans ; Medical sciences ; Nicotine ; Nicotine - administration &amp; dosage ; nicotine patches ; Short Report ; Smoking Cessation ; Time Factors ; Tobacco, tobacco smoking ; Toxicology ; Transdermal medication</subject><ispartof>Heart (British Cardiac Society), 1997-12, Vol.78 (6), p.617-618</ispartof><rights>British Cardiac Society</rights><rights>1998 INIST-CNRS</rights><rights>Copyright: 1997 British Cardiac Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b572t-132699ef78065dd2c2332451584221b220a6581c698451ee2d407d696629a0f03</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1892325/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1892325/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2083227$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9470884$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Richmond, Robyn L</creatorcontrib><creatorcontrib>Kehoe, Linda</creatorcontrib><creatorcontrib>Neto, Abilio Cesar de Almeida</creatorcontrib><title>Three year continuous abstinence in a smoking cessation study using the nicotine transdermal patch</title><title>Heart (British Cardiac Society)</title><addtitle>Heart</addtitle><description>A total of 305 subjects from Sydney were randomly allocated to receive either an active (24 hour transdermal nicotine patch over a 10 week course) or placebo nicotine patch. All subjects participated in a multicomponent cognitive–behavioural smoking cessation programme over five weeks in two-hour group sessions. The continuous abstinence rates at three years (validated by expired carbon monoxide) were 13.8% for the active group and 5.2% for placebo group (p = 0.011). The active nicotine patch with behavioural therapy achieved more than double the abstinence rates early in treatment compared with placebo and this difference was maintained throughout the three year follow up.</description><subject>Administration, Cutaneous</subject><subject>Behavior Therapy</subject><subject>Biological and medical sciences</subject><subject>Combined Modality Therapy</subject><subject>Confidence intervals</subject><subject>Drug Administration Schedule</subject><subject>Ganglionic Stimulants - administration &amp; dosage</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Nicotine</subject><subject>Nicotine - administration &amp; dosage</subject><subject>nicotine patches</subject><subject>Short Report</subject><subject>Smoking Cessation</subject><subject>Time Factors</subject><subject>Tobacco, tobacco smoking</subject><subject>Toxicology</subject><subject>Transdermal medication</subject><issn>1355-6037</issn><issn>1468-201X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNp9kUuLFDEUhQtRxnF051YIKOPGavOovDaC0_jCQUHGB25CKpWaSk9V0iYpsf-9Kbpp1IWrXHK-HE7uqaqHCK4QIuz5EPOKixVbMcRvVaeoYaLGEH27XWZCac0g4XereyltIISNFOykOpENh0I0p1V7NURrwc7qCEzw2fk5zAnoNpXRemOB80CDNIUb56-BsSnp7IIHKc_dDsxpuc2DBd6ZsDwBOWqfOhsnPYKtzma4X93p9Zjsg8N5Vn1-_epq_ba-_Pjm3frlZd1SjnONCGZS2p4LyGjXYYMJwQ1FVDQYoxZjqBkVyDApyq21uGsg75hkDEsNe0jOqhd73-3cTrYz1pcoo9pGN-m4U0E79bfi3aCuw0-FhMQE02JwfjCI4cdsU1aTS8aOo_a2LEVxSSmBjBTw8T_gJszRl88pVOJzgXGDC_VsT5kYUoq2P0ZBUC3NqdKc4kIxVZor-KM_4x_hQ1VFf3LQdTJ67MuajUtHDENBMF5s6j3mUra_jrKON4pxwqn68GWt3n9l3yW9-KQW26d7vp02_w_4GxdrvUM</recordid><startdate>19971201</startdate><enddate>19971201</enddate><creator>Richmond, Robyn L</creator><creator>Kehoe, Linda</creator><creator>Neto, Abilio Cesar de Almeida</creator><general>BMJ Publishing Group Ltd and British Cardiovascular Society</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19971201</creationdate><title>Three year continuous abstinence in a smoking cessation study using the nicotine transdermal patch</title><author>Richmond, Robyn L ; Kehoe, Linda ; Neto, Abilio Cesar de Almeida</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b572t-132699ef78065dd2c2332451584221b220a6581c698451ee2d407d696629a0f03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Administration, Cutaneous</topic><topic>Behavior Therapy</topic><topic>Biological and medical sciences</topic><topic>Combined Modality Therapy</topic><topic>Confidence intervals</topic><topic>Drug Administration Schedule</topic><topic>Ganglionic Stimulants - administration &amp; dosage</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Nicotine</topic><topic>Nicotine - administration &amp; dosage</topic><topic>nicotine patches</topic><topic>Short Report</topic><topic>Smoking Cessation</topic><topic>Time Factors</topic><topic>Tobacco, tobacco smoking</topic><topic>Toxicology</topic><topic>Transdermal medication</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Richmond, Robyn L</creatorcontrib><creatorcontrib>Kehoe, Linda</creatorcontrib><creatorcontrib>Neto, Abilio Cesar de Almeida</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Science Journals</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Heart (British Cardiac Society)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Richmond, Robyn L</au><au>Kehoe, Linda</au><au>Neto, Abilio Cesar de Almeida</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Three year continuous abstinence in a smoking cessation study using the nicotine transdermal patch</atitle><jtitle>Heart (British Cardiac Society)</jtitle><addtitle>Heart</addtitle><date>1997-12-01</date><risdate>1997</risdate><volume>78</volume><issue>6</issue><spage>617</spage><epage>618</epage><pages>617-618</pages><issn>1355-6037</issn><eissn>1468-201X</eissn><abstract>A total of 305 subjects from Sydney were randomly allocated to receive either an active (24 hour transdermal nicotine patch over a 10 week course) or placebo nicotine patch. All subjects participated in a multicomponent cognitive–behavioural smoking cessation programme over five weeks in two-hour group sessions. The continuous abstinence rates at three years (validated by expired carbon monoxide) were 13.8% for the active group and 5.2% for placebo group (p = 0.011). The active nicotine patch with behavioural therapy achieved more than double the abstinence rates early in treatment compared with placebo and this difference was maintained throughout the three year follow up.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and British Cardiovascular Society</pub><pmid>9470884</pmid><doi>10.1136/hrt.78.6.617</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1355-6037
ispartof Heart (British Cardiac Society), 1997-12, Vol.78 (6), p.617-618
issn 1355-6037
1468-201X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1892325
source Open Access: PubMed Central
subjects Administration, Cutaneous
Behavior Therapy
Biological and medical sciences
Combined Modality Therapy
Confidence intervals
Drug Administration Schedule
Ganglionic Stimulants - administration & dosage
Humans
Medical sciences
Nicotine
Nicotine - administration & dosage
nicotine patches
Short Report
Smoking Cessation
Time Factors
Tobacco, tobacco smoking
Toxicology
Transdermal medication
title Three year continuous abstinence in a smoking cessation study using the nicotine transdermal patch
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T04%3A27%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Three%20year%20continuous%20abstinence%20in%20a%20smoking%20cessation%20study%20using%20the%20nicotine%20transdermal%20patch&rft.jtitle=Heart%20(British%20Cardiac%20Society)&rft.au=Richmond,%20Robyn%20L&rft.date=1997-12-01&rft.volume=78&rft.issue=6&rft.spage=617&rft.epage=618&rft.pages=617-618&rft.issn=1355-6037&rft.eissn=1468-201X&rft_id=info:doi/10.1136/hrt.78.6.617&rft_dat=%3Cproquest_pubme%3E79553063%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b572t-132699ef78065dd2c2332451584221b220a6581c698451ee2d407d696629a0f03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1780782242&rft_id=info:pmid/9470884&rfr_iscdi=true